In a colorectal cancer model, GSK126 reduced the infiltration, proliferation, and IFNγ production of CD8+ T cells, mediated by increased myeloid-derived suppressor cells (MDSC; ref. 50). This evidence concerns the gene CD8A and colorectal cancer.